Moreover, systems-level network analysis identifies critical regulatory nodes, particularly activation of the FOXO1–FOXO3a axis, presenting actionable targets for precision medicine strategies in NSCLC patients. The gene discussed is FOXO1; the disease is non-small cell lung carcinoma.